Alpha Tau Medical to Participate in June Investor Conferences
24 Mai 2023 - 10:01PM
Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:
DRTS, DRTSW), the developer of the innovative alpha-radiation
cancer therapy Alpha DaRT™, today announced that management will
participate in the following investor conferences.
Event: |
Jefferies Healthcare Conference |
Format: |
Presentation and 1-on-1 meetings |
Date: |
Wednesday, June 7 |
Time: |
2:30 p.m. Eastern Time |
Location: |
New York, NY |
Event: |
Sidoti Small-Cap Virtual Conference |
Format: |
Presentation and 1-on-1 meetings |
Date: |
June 14-15 |
Location: |
Virtual |
Registration: |
https://www.meetmax.com/sched/event_94441/investor_reg_new.html?attendee_role_id=SIDOTI_INVESTOR |
Event: |
Citi European Healthcare Conference |
Format: |
1-on-1 meetings |
Date: |
Thursday, June 22 |
Location: |
Virtual |
About Alpha DaRT™
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is
designed to enable highly potent and conformal alpha-irradiation of
solid tumors by intratumoral delivery of radium-224 impregnated
sources. When the radium decays, its short-lived daughters are
released from the sources and disperse while emitting high-energy
alpha particles with the goal of destroying the tumor. Since the
alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims
to mainly affect the tumor, and to spare the healthy tissue around
it.
About Alpha Tau Medical, Ltd.
Founded in 2016, Alpha Tau is an Israeli medical device company
that focuses on research, development, and potential
commercialization of the Alpha DaRT for the treatment of solid
tumors. The technology was initially developed by Prof. Itzhak
Kelson and Prof. Yona Keisari from Tel Aviv University.
Investor Relations Contact:IR@alphatau.com
Alpha Tau Medical (NASDAQ:DRTS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Alpha Tau Medical (NASDAQ:DRTS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024